相似文献
1
COVID-19 in a series of patients with aspirin-exacerbated respiratory disease.一系列阿司匹林加重性呼吸道疾病患者中的新型冠状病毒肺炎
J Allergy Clin Immunol Pract. 2021 Jul;9(7):2900-2903. doi: 10.1016/j.jaip.2021.04.060. Epub 2021 May 18.
2
Multidisciplinary single-center outcomes compared to two-center outcomes for the treatment of aspirin exacerbated respiratory disease.阿司匹林加重性呼吸疾病治疗的多学科单中心与双中心治疗结果比较
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2498-2500. doi: 10.1016/j.jaip.2021.01.032. Epub 2021 Feb 3.
3
A retrospective analysis of bronchiectasis in patients with aspirin-exacerbated respiratory disease.阿司匹林加重性呼吸系统疾病患者支气管扩张的回顾性分析。
J Allergy Clin Immunol Pract. 2020 Sep;8(8):2799-2801. doi: 10.1016/j.jaip.2020.04.017. Epub 2020 Apr 21.
4
Leukotriene-Associated Rash in Aspirin-Exacerbated Respiratory Disease.阿司匹林加重性呼吸系统疾病中的白三烯相关皮疹
J Allergy Clin Immunol Pract. 2020 Oct;8(9):3170-3171. doi: 10.1016/j.jaip.2020.06.061. Epub 2020 Jul 29.
5
Aspirin-exacerbated respiratory disease: personalized medical and surgical approaches.阿司匹林加重性呼吸疾病：个性化医疗与手术方法
Int Forum Allergy Rhinol. 2020 Sep;10(9):1035-1036. doi: 10.1002/alr.22634. Epub 2020 Jul 7.
6
Mepolizumab does not prevent all aspirin-induced reactions in patients with aspirin-exacerbated respiratory disease: A case series.美泊利单抗不能预防阿司匹林加重性呼吸系统疾病患者的所有阿司匹林诱发反应：病例系列报道
J Allergy Clin Immunol Pract. 2021 Mar;9(3):1384-1385. doi: 10.1016/j.jaip.2020.09.007. Epub 2020 Sep 19.
7
Dupilumab as an adjunct to surgery in patients with aspirin-exacerbated respiratory disease.度普利尤单抗作为阿司匹林加重性呼吸道疾病患者手术的辅助治疗药物。
Ann Allergy Asthma Immunol. 2022 Mar;128(3):326-328. doi: 10.1016/j.anai.2021.11.020. Epub 2021 Dec 1.
8
Type 2 biologics reduce cumulative steroid exposure in aspirin-exacerbated respiratory disease.2型生物制剂可减少阿司匹林诱发的呼吸道疾病中的累积类固醇暴露。
Ann Allergy Asthma Immunol. 2022 Nov;129(5):642-643. doi: 10.1016/j.anai.2022.07.023. Epub 2022 Jul 28.
9
Aspirin-exacerbated respiratory disease: not always "adult-onset".阿司匹林加重性呼吸疾病：并非总是“成人起病”。
J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):756-8. doi: 10.1016/j.jaip.2016.05.016.
10
Pediatric-onset aspirin-exacerbated respiratory disease: Clinical characteristics, prevalence, and response to dupilumab.儿童期起病的阿司匹林诱发的呼吸道疾病：临床特征、患病率及对度普利尤单抗的反应
J Allergy Clin Immunol Pract. 2022 Sep;10(9):2466-2468. doi: 10.1016/j.jaip.2022.05.016. Epub 2022 May 25.
Zotero 插件